Edgar R. Iii Smith

Director Edgar R. Iii Smith bought 109,051 shares of FGBI at $9.17; 4 of 4 prior buys at this ticker were well-timed at the 90-day mark.

Director Edgar R. Iii Smith purchased 109,051 shares (109.1K shares) at $9.17 on 2026-04-30, increasing his holdings by 16.1% to 784,400 shares. His prior trading history at FGBI shows a strong pattern of timing: all 4 prior measurable buys achieved positive 90-day returns (ranging from +50.4% to +91.3%), indicating a consistent ability to accumulate shares ahead of price appreciation. His cross-ticker track record further supports this pattern, with 14 prior buys delivering an average 90-day return of +33.1% and a 69.23% win rate. However, this bullish signal is tempered by company fundamentals: FGBI was unprofitable over its most recent full fiscal year, and current market performance (stock up 17.1% over 30 days and 28.1% over 90 days) suggests material price momentum already underway rather than a contrarian or value-based accumulation.

Director Smith Edgar R. III bought 138.1K shares of FGBI at $7.77 on 2026-03-31; stock up 71.0% in 90d and he's 5-for-5 on timing at this ticker.

Smith Edgar R. III, as Director, purchased 138,083 shares at $7.77, increasing his holdings from 537,266 to 675,349 shares (+25.7%). His prior five purchases at FGBI all posted positive 90-day returns (range: +50.4% to +91.3%), establishing a consistent track record of acquisitions made ahead of subsequent stock appreciation at this specific company. The current price of $9.20 reflects a 71.0% gain over 90 days from the transaction date, aligning with his historical timing success at FGBI. However, the company reported net income of -$45.0M over its most recent full fiscal year and carries a market cap of $145.3M, meaning the stock's recent momentum exists despite negative fundamentals. A cluster pattern is also present: 2 other insiders purchased shares within the past 14 days, suggesting coordinated conviction among multiple board members.

Director Smith Edgar R. III buys 208,996 shares of FGBI at $5.40 on 2025-12-31, raising stake 63.7%; concurrent cluster buy and negative fundamentals warrant attention.

Smith Edgar R. III purchased 208,996 shares at $5.40, increasing his holdings from 328,270 shares to 537,266 shares—a 63.7% increase in his position. The stock is currently trading at $5.38, down 52.9% from its 52-week high of $11.43 and down 39.0% over the past 90 days, despite a near-term 5.9% gain over the past 30 days. At the same-ticker level, Smith has completed four prior purchases on 2025-11-20 and one on 2025-11-17, with 30-day returns ranging from 1.8% to 5.2%, though one prior buy on 2025-11-17 returned -12.3% at the 30-day mark. The company reported net income of -$45,003,000.00, and this buy occurred as part of a cluster pattern with two other insiders purchasing within the past 14 days. The scale of accumulation, combined with negative earnings and multi-insider buying activity, suggests material consideration of value at current depressed price levels, though the stock's steep decline from recent highs and negative profitability create offsetting risks.

Director Smith Edgar R. III bought 21,300 shares of FGBI at blended average $5.00 in 5 transactions on Nov 17-20, amid -65.4% decline from 52-week high and -45.0M net income.

Smith Edgar R. III, a director, executed 5 separate purchases totaling 21,300 shares for $106,480.00 between November 17–20, 2025, at prices ranging from $4.81 to $5.78 and a blended average of $5.00. The transactions increased his holdings by 6.7%, from 320,137 to 341,437 shares. The purchases occur against a backdrop of significant headwinds: the stock has declined 65.4% from its 52-week high of $14.75 and 36.2% over the past 30 days, while the company reported net income of -$45,003,000.00 and trades at a P/E ratio of 6.30. His same-ticker history shows mixed timing: 2 of 4 prior measurable buys at FGBI produced positive 90-day returns (April 2 and April 3 trades), while 2 of 4 produced negative 90-day returns (May 12 and September 30 trades). The accumulation during a period of steep price deterioration and negative earnings warrants close attention to whether it reflects conviction or reflects constraints—without additional context on composition or transaction flags, the characterization remains ambiguous.

Director Smith bought 141,328 shares at $8.05; stock down 46.7% from 52-week high, held at $7.86; negative 90-day trend conflicts with prior wins at ticker

Smith Edgar R. III purchased 141,328 shares at $8.05 on 2025-09-30, raising his position to 328,270 shares (a +75.6% increase). The stock trades at $7.86, down 46.7% from its 52-week high and declining 11.3% over 90 days. Examining his same-ticker history at FGBI reveals a mixed record: 2 of his 5 prior buys were well-timed at the 90-day mark, but the most recent buy on 2025-06-30 delivered negative returns, and the May and April transactions show mostly poor longer-term results. The company reports a net loss of $7,303,000.00, a bearish fundamental backdrop that contextualizes the deteriorating stock momentum. A cluster pattern is present (2 other insiders also bought within 14 days), which suggests coordinated confidence or a pre-planned capital event rather than a solitary conviction signal.

Director Edgar Smith III buys 30,865 shares of FGBI at $8.10; cluster activity by 4 other insiders within 14 days amid negative earnings.

Smith Edgar R. III, a Director, purchased 30,865 shares at $8.10 for $250,006.50, increasing his stake by 19.8% to 186,942 shares. The timing coincides with a broader cluster, with 4 other insiders buying within the past 14 days, suggesting coordinated or reactive positioning. However, context tempers conviction: the company reported negative net income of $-6,166,000.00, and the stock trades at a elevated P/E of 28.58 despite being down 39.9% from its 52-week high of $14.75. Smith's same-ticker history at FGBI is mixed—three of four prior measurable outcomes showed positive 90-day returns, but his most recent FGBI purchase on 2025-05-12 has posted a 30-day loss of -12.1%. The cluster buy pattern warrants monitoring, but deteriorating fundamentals and recent underperformance limit conviction signals.

Director Smith buys 6,725 FGBI shares at $9.66; stock down -36.6% from 52-week high; recent 5-trade pattern shows 3 consecutive gains through early April.

Director Smith Edgar R. III purchased 6,725 shares at $9.66, increasing his stake by 53.0% to 19,407 shares post-transaction. The purchase occurs at a significant discount to the 52-week high of $14.75, though the stock is trading -6.0% lower over the past 30 days and remains -36.6% below its annual peak. At the FGBI ticker level, Smith's prior trades show a strong recent pattern: three consecutive buys through early April 2025 each posted 30-day returns of +21.2%, +9.8%, and +18.5%, though these outcomes are not yet measurable at the 90-day horizon. His cross-ticker track record shows 6 prior buys averaging +10.0% over 30 days with a 100% 90-day win rate, indicating consistent execution timing historically. The fundamental picture presents a headwind: the company reported net income of $-6,166,000.00 and trades at a P/E of 30.16 on a $120.5M market cap. The frequency and scale of Smith's buying activity—particularly the three purchases in early April followed by this May 12 acquisition—warrants attention to whether the director is responding to undervaluation or other material non-public factors.

FGBI Director Smith Edgar R. III buys 5,233 shares for $40,838.39; holdings rise 70.3% to 12,682 shares

Director Smith Edgar R. III acquired 5,233 shares across two transactions on 2025-04-02 and 2025-04-03 at a blended average price of $7.80, investing $40,838.39 total. This purchase increased his post-transaction holdings to 12,682 shares, a 70.3% increase from his pre-transaction base of 7,449 shares. His prior trade history at FGBI shows a pattern of well-timed accumulation: three of three prior buys at this ticker posted positive 90-day returns, with the most recent August 2024 buy gaining 2.7% by the 90-day mark. The current stock price of $9.49 is 21.5% above his blended purchase price, suggesting the transactions occurred in a depressed zone relative to recent trading activity (stock is -35.7% from its 52-week high but up 15.2% in the past 30 days). Across all tickers, Smith's open-market buy track record shows a 100.0% 90-day win rate with an average 90-day return of 3.9%, indicating consistent accuracy in timing accumulation.

Director Smith buys 98.5K shares of FGBI at $8.47; stock -47.6% from 52-week high as cluster buying emerges

Smith Edgar R. III purchased 98,460 shares at $8.47 on 2025-04-02, establishing a first full position in FGBI and committing $833,956.20. The timing follows significant recent weakness: the stock trades at $7.73, down 47.6% from its 52-week high of $14.75 and down 31.6% over 90 days. At this price, FGBI trades at a P/E of 6.04 on net income of $1,927,000.00, suggesting a compressed valuation. His same-ticker history shows 3 prior buys with measurably well-timed outcomes at the 90-day mark, and his cross-ticker track record spans 4 prior buys with a 100% 90-day win rate. Notably, 5 other insiders also bought within the past 14 days, establishing a cluster buy pattern that may reflect internal confidence amid the recent drawdown. However, the current price of $7.73 has already declined 6.1% in the past 30 days since the transaction, so near-term outcomes remain unfavorable.

Director Smith Edgar R. III bought 1,935 shares of FGBI at $10.36 on 2024-08-12; stock now at $10.47, trending +9.1% in 30 days.

Director Smith Edgar R. III purchased 1,935 shares at $10.36, adding to his substantial holding of 340,637 shares post-transaction. His cross-ticker track record shows 2 prior buys with an average 90-day return of +4.5% and a 100.00% win rate, and his two prior purchases at FGBI (October 2022) also both posted +4.5% 90-day returns, indicating consistent timing execution at this ticker. The current stock price of $10.47 is 9.1% higher than 30 days ago, aligning with the positive near-term pattern, though the stock remains 19.5% below its 52-week high of $13.01. With a P/E of 10.37 and market cap of $130,924,386.99, the company operates at modest valuation multiples relative to its net income of $7,201,000.00. This purchase represents a modest 0.6% increase to his existing position and follows a demonstrated pattern of well-timed entry points at this security.